Canada Markets closed

PsyBio Therapeutics Corp. (PSYB.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0650-0.0100 (-13.33%)
At close: 01:38PM EDT
Full screen
Previous Close0.0750
Open0.0700
Bid0.0650 x N/A
Ask0.0700 x N/A
Day's Range0.0600 - 0.0700
52 Week Range0.0600 - 0.5500
Volume40,020
Avg. Volume142,975
Market Cap7.342M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1100
Earnings DateJun 01, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    PsyBio Therapeutics Develops Commercial Purification Process for Second Generation Psycho-Targeted Compound

    PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), a fully integrated and intellectual property driven biotechnology company developing novel, bespoke psychoactive medicinal candidates targeting the potential treatment of mental health challenges, neurological disorders and other human health conditions, today reported that it has achieved a commercially scalable purification method for one of its second generation compounds. This manufacturing process achievement

  • CNW Group

    PsyBio Therapeutics Initiates Blood-Brain Barrier Permeability Testing for Pipeline Compounds to Enhance Portfolio Development

    PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), a fully integrated and intellectual property driven biotechnology company developing novel, bespoke psychoactive medicinal candidates targeting the potential treatment of mental health challenges, neurological disorders and other human health conditions, today reported that it has expanded its pre-clinical pipeline activities by initiating blood-brain barrier permeability testing. This additional testing procedure

  • GlobeNewswire

    KCSA Psychedelics Virtual Investor Conference Presentations Now Available for On-Demand Viewing

    NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the April 27th and 28th KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing. REGISTER OR LOGIN NOW AT: https://bit.ly/3OGHgD4 The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section. Comp